A deeper understanding of the alterations occurring in the GM of patients on different therapeutic regimens could help set up individualized and supportive therapeutic strategies providing patients with more effective and safe care (Picchianti-Diamanti et al., 2018)
doi: 10.1002/hbm.24380 9 AlBattiT
Clinical trials demonstrate average weight loss of 10 to 15% of total body weight over 68 weeks at the 2.4 mg weekly dose
Glucose transporters (GLUTs) Glycolysis is stressed in most cancer cells, causing them to frequently express large amounts of glucose transporters, particularly GLUT1, which is an ingrained cellular structure used to move glucose across membranes
However, various factors such as aging, stress, and environmental pollutants can deplete its levels, necessitating external supplementation
Dont layer too many actives